Saturday - March 07, 2026

Category Archives: Science

IVD Reagents Market Set to Reach $87.41 Billion by 2029 Amid Rising Demand for Advanced Diagnostic Testing

IVD Reagents Market by Type (Antibodies, Nucleic Acid Probes), technology (Hematology), Application (Genetic Testing, Autoimmune disease), Test Type (Laboratory Test, Point-of-care Tests), End User (Hospitals & Clinics) & Region – Global Forecast to 2029 According to MarketsandMarkets™, The report “IVD … Continue reading →

BigData Boutique Launches Enterprise-Grade OpenSearch Distribution

Itamar Syn-Hershko, CTO and Founder of BigData Boutique and an OpenSearch Ambassador, speaking about the launch of the company’s Enterprise-Hardened OpenSearch Distribution designed for mission-critical environments. BigData Boutique has launched an enterprise-grade OpenSearch distribution designed for organizations running mission-critical search … Continue reading →

Immune Thrombocytopenia Clinical Trial Pipeline Expands as 30+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Immune Thrombocytopenia Pipeline Insight 2026” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Immune Thrombocytopenia pipeline landscape. It covers the Immune Thrombocytopenia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Renal Cancer Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Renal Cancer Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Renal Cancer pipeline landscape. It covers the Renal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Renal Cell Carcinoma Treatment Pipeline Shows Strong Momentum as 70+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Renal Cell Carcinoma Pipeline Insight 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in the Renal Cell Carcinoma pipeline landscape. It covers the Renal Cell Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Rheumatoid Arthritis Clinical Trial Pipeline Expands as 75+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Rheumatoid Arthritis Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Rheumatoid Arthritis (RA) pipeline landscape. It covers the Rheumatoid Arthritis pipeline drug profiles, including clinical and nonclinical stage products. It also … Continue reading →

Small Cell Lung Cancer Clinical Trial Pipeline Shows Potential with Active Contributions from 100+ Key Companies | DelveInsight

DelveInsight’s, “Small Cell Lung Cancer Pipeline Insight 2026” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Small Cell Lung Cancer pipeline landscape. It covers the Small Cell Lung Cancer pipeline drug profiles, including clinical and nonclinical … Continue reading →

Small Lymphocytic Lymphoma Clinical Trial Pipeline Accelerates as 80+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Small Lymphocytic Lymphoma Pipeline Insight, 2026” report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Small Lymphocytic Lymphoma pipeline landscape. It covers the Small Lymphocytic Lymphoma pipeline drug profiles, including clinical and non-clinical stage products. It … Continue reading →

Oropharyngeal Cancer Treatment Pipeline Shows Strong Momentum as 10+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Oropharyngeal Cancer Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Oropharyngeal Cancer pipeline landscape. It covers the Oropharyngeal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Synovial Sarcoma Clinical Trial Pipeline Shows Potential with Active Contributions from 15+ Key Companies | DelveInsight

DelveInsight’s, “Synovial Sarcoma Pipeline Insight, 2026” report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Synovial Sarcoma pipeline landscape. It covers the Synovial Sarcoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →